Ignite Creation Date:
2025-12-24 @ 9:43 PM
Ignite Modification Date:
2025-12-28 @ 12:18 PM
Study NCT ID:
NCT00633932
Status:
COMPLETED
Last Update Posted:
2010-12-20
First Post:
2008-03-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Reflux Esophagitis Phase III Study (Initial Treatment)
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-12
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2008-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-04
First Submit QC Date:
None
Study First Post Date:
2008-03-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-12-10
Results First Submit QC Date:
None
Results First Post Date:
2010-04-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-12-02
Last Update Post Date:
2010-12-20
Last Update Post Date Type:
ESTIMATED